Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Zosuquidar (LY335979) for MDR Research
2026-08-12
Zosuquidar (LY335979) 3HCl provides a selective way to test whether P-glycoprotein drives chemotherapy failure, rather than merely increasing drug exposure. This workflow-focused guide shows how to combine P-gp efflux pump inhibition with viability, transport, intracellular drug, and pharmacokinetic measurements.
-
Pemetrexed: A Folate–DNA Repair Assay Framework
2026-08-12
Pemetrexed disodium is more than a cytotoxic benchmark: it can anchor experiments connecting folate-dependent nucleotide stress with DNA-repair phenotypes. This article develops a decision framework for cancer chemotherapy research, with practical guidance for mesothelioma and lung tumor models.
-
Plant Cell Lysis Buffer for WB and IP
2026-08-11
Plant Cell Lysis Buffer for WB and IP (SKU K1126) is a non-denaturing extraction reagent containing 1% Triton X-100 and protease/phosphatase inhibitors. It is designed for protein sample preparation from plant cells, tissues, and protoplasts before Western blotting, immunoprecipitation, co-immunoprecipitation, PAGE, or ELISA.
-
Ruxolitinib phosphate: JAK Signaling in ATC
2026-08-11
Ruxolitinib phosphate (INCB018424) offers a precise way to interrogate JAK1/2–STAT3 biology. This article translates recent anaplastic thyroid carcinoma findings into practical, mechanism-aware assay decisions.
-
BRCAness Predicts Olaparib Response in Mesothelioma
2026-08-10
Borchert et al. linked homologous recombination repair gene-expression patterns with olaparib sensitivity in malignant pleural mesothelioma, particularly in BAP1-mutated cells. The study combines in vitro treatment experiments with expression analysis of 91 clinical samples, providing a rationale for biomarker-guided PARP inhibition while underscoring the need for clinical validation.
-
Targeted EPO mRNA Nanoparticles for SCI Repair
2026-08-09
A 2026 Materials Today Bio study developed mannose-modified lipid nanoparticles to deliver EPO mRNA to CD206-enriched inflammatory macrophages and microglia after spinal cord injury. In mice, the approach improved lesion-localized EPO expression, reduced neuroinflammation and ferroptosis-associated damage, and enhanced motor recovery, while highlighting the importance of targeted delivery for mRNA-based neurorepair.
-
Lambda Protein Phosphatase for BMAL1 Studies
2026-08-08
Lambda Protein Phosphatase provides a practical dephosphorylation control for testing whether BMAL1 phosphorylation influences antibody recognition, transcriptional activity, or condensate behavior. This workflow connects the 2026 BMAL1 phase-separation findings with reproducible phosphorylation analysis while emphasizing controls, buffer compatibility, and troubleshooting.
-
MDL 28170: A Mechanism-to-Assay Guide
2026-08-07
MDL 28170 is a selective calpain inhibitor that connects cysteine protease biology with rigorous neuroprotection research. This guide translates recent BDNF/TrkB findings into practical assay decisions while defining how far evidence can be extended across injury, cardiac, and infection models.
-
Zosuquidar (LY335979): Optimizing P-gp Inhibition in MDR Can
2026-08-07
Zosuquidar (LY335979) 3HCl enables robust, selective reversal of P-glycoprotein-mediated multidrug resistance in cancer research. This article delivers actionable workflows, performance data, and troubleshooting insights to maximize drug sensitization and experimental reproducibility using APExBIO's trusted formulation.
-
ZDHHC4-Mediated Palmitoylation Regulates TRPV1 and Inflammat
2026-08-06
This study reveals that the palmitoyl acyltransferase ZDHHC4 directly palmitoylates TRPV1, targeting specific cysteine residues and promoting its lysosomal degradation. These findings clarify a novel regulatory mechanism underlying the relief phase of inflammatory pain and suggest new avenues for modulating nociception through post-translational modification.
-
OsALY4: An m5C-mRNA Reader Enhancing Stress Tolerance in Ric
2026-08-06
Gao et al. identify OsALY4 as a key m5C-mRNA reader that facilitates the nuclear export of methylated mRNAs, directly enhancing chilling and salt tolerance in rice. This discovery uncovers a new mechanistic layer in plant adaptation to abiotic stress and provides a foundation for further translational research in crop resilience.
-
Biotin-HPDP: Precision Thiol Labeling for Redox Proteomics
2026-08-05
Biotin-HPDP enables precise, reversible thiol-specific protein labeling, driving advanced detection of dynamic post-translational modifications and affinity purification. Its unique chemistry empowers translational researchers to dissect redox signaling and membrane localization events pivotal in immune response and neurodegeneration.
-
Iron-Dependent KDM4D Activity Regulates MSC Quiescence via P
2026-08-05
This study uncovers how iron-dependent KDM4D activity modulates the activation of mesenchymal stem cells (MSCs) by orchestrating chromatin changes at the PIK3R3 promoter, thereby regulating the PI3K-Akt-Foxo1 pathway. The findings illuminate a mechanistic link between iron deficiency, stem cell quiescence, and bone loss, with clear implications for bone metabolism research and targeted pharmacological intervention.
-
Amikacin Sulfate: Optimizing Intracellular Delivery in NTM R
2026-08-04
Amikacin Sulfate enables targeted, high-efficacy treatment of non-tuberculous mycobacterial infections by leveraging its potent activity and efficient intracellular uptake. This guide details protocol enhancements, troubleshooting, and advanced applications for maximizing research outcomes with APExBIO's Amikacin Sulfate.
-
Tunicamycin: Precision N-Glycosylation Inhibition for ER Str
2026-08-04
Explore how Tunicamycin, a potent N-glycosylation inhibitor, enables precise manipulation of endoplasmic reticulum stress in advanced cell biology and toxicology research. This article uniquely emphasizes mechanistic depth, protocol optimization, and translational insight beyond standard application guides.